DM, A. (2025). PCSK9 inhibitors and post-PCI antiplatelet therapy: Weighing bleeding vs benefit. International journal of cardiology, 439, 133600. https://doi.org/10.1016/j.ijcard.2025.133600
Chicago Style (17th ed.) CitationDM, Awad. "PCSK9 Inhibitors and Post-PCI Antiplatelet Therapy: Weighing Bleeding Vs Benefit." International Journal of Cardiology 439 (2025): 133600. https://doi.org/10.1016/j.ijcard.2025.133600.
MLA (9th ed.) CitationDM, Awad. "PCSK9 Inhibitors and Post-PCI Antiplatelet Therapy: Weighing Bleeding Vs Benefit." International Journal of Cardiology, vol. 439, 2025, p. 133600, https://doi.org/10.1016/j.ijcard.2025.133600.
Warning: These citations may not always be 100% accurate.